Codexis, Inc. (CDXS) Stock Price

CDXSStock
$1.6842.56%52W
Market Cap$183.97M
P/E
PEG Ratio13.53
Div yield
Beta2.52

CDXS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)30.63%
Price vs S&P 500 (4W)7.61%
PEG Ratio13.53
VGM Score46.78

CDXS Earnings Surprise History

Q2 25-0.16est. -0.15
Q3 25-0.22est. -0.15
Q4 250.14est. -0.04
Q1 26-0.10est. -0.10
Q2 26-0.13est. -0.12

CDXS Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.08
4.08
4.08
4.08

Industry Peers — Industrial Chemicals(25)

About Codexis, Inc.

Codexis develops proprietary enzymatic solutions for biopharmaceutical and diagnostics manufacturing using its CodeEvolver technology platform. The company's enzymes improve production efficiency through higher yields and reduced energy consumption while enabling scaled manufacturing of RNAi therapeutics via its ECO Synthesis platform. Applications span small molecule pharmaceuticals, nucleic acid synthesis, and genomic diagnostics, with primary revenue generation from the Americas.